From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
2C-F 2DACS.svg
2C-F 3Dan.gif
Legal status
Legal status
CAS Number
  • 207740-15-6 ☒N
PubChem CID
  • 44719499
  • 21106223 ☑Y
  • O01SQJ93TV
CompTox Dashboard (EPA)
  • DTXSID70660357
Chemical and physical data
Formula C10H14FNO2
Molar mass 199.22 g/mol g·mol−1
3D model (JSmol)
  • Interactive image
 ☒N☑Y (what is this?)   (verify)

2C-F, or 4-fluoro-2,5-dimethoxyphenethylamine, is a lesser-known psychedelic drug of the 2C family. It was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 250 mg. 2C-F may be found as a brownish freebase oil, or as a white crystalline hydrochloride salt.


Very little data exists about the pharmacological properties, metabolism, and toxicity of 2C-F.


At a dose of 250 milligrams, 2C-F produces modest closed-eye visuals accompanied by lethargy.[1] The amphetamine analogue DOF is likely to be more active than the phenethylamine derivative 2C-F, and in animal trials DOF was found to be 1/6 the activity of the potent hallucinogen DOI, which would make an active dose of DOF likely to be in the 6-18 milligram range, although it is not known to have been tested in humans.




As of October 31st, 2016; 2C-F is a controlled substance (Schedule III) in Canada. http://gazette.gc.ca/rp-pr/p2/2016/2016-05-04/html/sor-dors72-eng.php


  1. ^ Shulgin, Alexander; Ann Shulgin (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.

External links

  • 2C-F Entry in PiHKAL
  • 2C-F Entry in PiHKAL • info
Retrieved from "https://en.wikipedia.org/w/index.php?title=2C-F&oldid=898174018"
This content was retrieved from Wikipedia : http://en.wikipedia.org/wiki/2C-F
This page is based on the copyrighted Wikipedia article "2C-F"; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA